Peter Sephton
Analyst · Anthony Kure with KeyBanc
Thanks, Matt. And turn your attention now to Slide #12. Sales in EMEA were down 7.5% to $97.9 million in the third quarter. The sales reduction is a combination of reduced organic sales of 3.3% and a negative impact of 4.7% from foreign currency translation. Acquisitions added 0.5%. This quarter compares unfavorably against quarter 3 of last year, where we had some stability in the European economy compared to this year, where we have a Eurozone crisis. Although this modest sales decline was noticeable in most countries of the EU-27, there continues to be differences in performance between the respective countries in EMEA. For instance, our U.K. business was down in the quarter as England has formally slipped back into recession, and our Spanish and Italian businesses although small, also showed significant sales declines against -- again, driven by difficult economic circumstances. Our business in Germany also showed negative organic sales growth as the uncertainties bubbling out of Southern Europe are having a negative impact on buying patterns throughout the Eurozone, although the underlying trends in Germany are good for both the economy and our businesses in this country.
On the other hand, our businesses in the Scandinavian countries continued to show resilience, and our businesses in Central Europe and the Middle East continue their strong fiscal 2012 performance by posting strong revenue and earnings growth.
Taking a look at our businesses by business stream, our Direct Marketing business saw core sales decline of 3.8%, driven mainly by its exposure to mature economies in the Eurozone. This decline was relatively broad based due to the macro economy. In order to mitigate this, we reallocated investments away from Southern Europe and the U.K. and invested in building our customer files in Germany and capitalized on leveraging cross-selling opportunities at our Securimed business, a first-aid business that we acquired in 2010, where not only sales continue to grow nicely, but we're also unlocking a new market segment for the medical products.
Our commitment to e-commerce as an opportunity to win new customers and service existing customers better continues to ramp up as we roll out our investment both in customer-facing and transactional processing software. We are seeing the benefits in the growth of sales through this channel.
Moving on now to our business streams. Our Brady business -- Brady Brand performed somewhat better, but here also, there were some small sales declines. Our efforts to increase exposure in emerging geographies and tailor our product offer to vertical market segments that are growing helped moderate the sales decline in Western Europe somewhat. However, as the majority of our business is driven by the EU-27, it couldn't quite compensate for this.
Against this economic malaise, we still see opportunities for market share growth and we continue to drive our installed base of printers in EMEA. And we are aggressively launching new differentiated products throughout our more mature economies, including the launch of the BMP 51 and the BBP 33 printers this quarter. We believe that we have the best range available on the market and are actively seeking new channel partners across EMEA to help drive and share our success.
We've also made a concerted effort to acquire in markets and geographies that help us rebalance our business away from the more mature economies in Europe. In March, we closed the acquisition of Grafo in South Africa. Grafo is a supplier of wire marking products in South Africa. Although a small acquisition for us, a solid company such as Grafo gives us a nice beachhead into Sub-Saharan Africa, which is one of our focus markets for geographic expansion. On May 2, we also completed 2 additional acquisitions. First, we acquired Runelandhs, which is a direct marketer of industrial and office equipment located in Sweden, with annual sales of approximately $19 million.
And we also closed the acquisition of Pervaco on May 2. Pervaco is a direct marketer of facility identification products based in Norway, with annual sales of approximately $60 million dollars. Runelandhs and Pervaco give us a much expanded presence in the Scandinavian region, which historically has been an area of under penetration for our direct marketing business stream.
All of these acquisitions were driven by a robust and planned business rationale to, firstly, expand our sales in both emerging high-growth economies and economies that have a more stable basis for growth by reallocating resources. Secondly, focus on companies that operate in product areas that link well to our own and where we can leverage product synergies. And thirdly, focus on bolt-on acquisitions in our core business streams, including direct marketing and workplace safety and efficiency products and product identification. Segment profit declined 11.6% to $25.6 million in the quarter. With the underlying strength of our gross margins, we were able to keep segment profit high at 26.1%, down slightly from 27.3% in the third quarter of 2011.
As I mentioned, we are investing in numerous growth areas and reallocating resources to high-growth opportunities, but we need to be realistic. And in the near term, it will be challenging to generate organic sales growth given the macroeconomic challenges that we face. As such, looking forward to the fourth quarter, we anticipate organic sales to be approximately flat to slightly down when compared to the prior year. Consistent with Frank's comments, we are highly focused on organic sales growth opportunities, driving Internet sales across all our businesses, driving new product sales, expanding our geographic reach deeper into Eastern Europe and Africa, as well as our ongoing focus on deeper penetration into selected vertical markets. We believe that these actions, along with the continued spending control, should significantly mitigate the negative macroeconomic forces throughout the Eurozone in the median term.
I'll now hand the call over to the Asia Pacific region with Stephen Millar. Over to you, Stephen.